Nemaura Medical AI Stock Analysis
Nemaura Medical (NMRD) AI Stock Analysis
Nemaura Medical
(Other OTC:NMRD)
No summary available
Nemaura Medical (NMRD) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $4,035
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- 0.0
- Beta (1Y)
- -134.47
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- US
- Employees
- 38
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
Nemaura Medical Business Overview & Revenue Model
Company Description
Nemaura Medical Inc. is a medical technology company dedicated to inventing, developing, and bringing to market diagnostic medical devices. Its flagship product, sugarBEAT, is an innovative, non-invasive continuous glucose monitoring (CGM) system. Th...
Nemaura Medical Risk Analysis
Nemaura Medical disclosed 37 risk factors in its most recent earnings report. Nemaura Medical reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksNemaura Medical Peers Comparison
Overall Rating
DXCM73Outperform
PODD73Outperform
TNDM60Neutral
SENS50Neutral
XTNT41Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| DXCM | 73Outperform | $30.35B | 32.17 | 36.50% | ― | 13.03% | 40.88% |
| PODD | 73Outperform | $10.36B | 24.79 | 29.48% | ― | 26.46% | 75.56% |
| TNDM | 60Neutral | $1.22B | -27.93 | -35.61% | ― | 6.73% | 76.54% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| SENS | 50Neutral | $550.00M | -4.52 | -186.15% | ― | 104.83% | -37.15% |
| XTNT | 41Neutral | $38.62M | -3.31 | -23.45% | ― | -14.27% | -132.84% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| NMRD | Nemaura Medical | 0.05 | 0.00 | 0.00% | |
| DXCM | Dexcom | 83.33 | 24.84 | 42.47% | |
| PODD | Insulet | 152.48 | -175.54 | -53.52% | |
| TNDM | Tandem Diabetes Care | 20.07 | 1.73 | 9.43% | |
| XTNT | Xtant Medical Holdings Inc | 0.27 | -0.41 | -60.32% | |
| SENS | Senseonics Holdings Inc. | 10.58 | 4.68 | 79.32% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.